共 88 条
[1]
Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients[J]. Abdulrahman A Aljumah,Mohamed A Saeed,Ahmed I Al Flaiw,Ibrahim H Al Traif,Abduljaleel M Al Alwan,Salem H Al Qurashi,Ghormallah A Al Ghamdi,Fayez F Al Hejaili,Mohammed A Al Balwi,Abdulla A Al Sayyari.World Journal of Gastroenterology. 2012(01)
[4]
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial[J] . Ira M Jacobson,Gregory J Dore,Graham R Foster,Michael W Fried,Monica Radu,Vladimir V Rafalsky,Larysa Moroz,Antonio Craxi,Monika Peeters,Oliver Lenz,Sivi Ouwerkerk-Mahadevan,Guy De La Rosa,Ronald Kalmeijer,Jane Scott,Rekha Sinha,Maria Beumont-Mauviel.The Lancet . 2014 (9941)
[5]
Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study[J] . Eric Lawitz,Mark S Sulkowski,Reem Ghalib,Maribel Rodriguez-Torres,Zobair M Younossi,Ana Corregidor,Edwin DeJesus,Brian Pearlman,Mordechai Rabinovitz,Norman Gitlin,Joseph K Lim,Paul J Pockros,John D Scott,Bart Fevery,Tom Lambrecht,Sivi Ouwerkerk-Mahadevan,Katleen Ca
[7]
Telaprevir pharmacokinetics in a hepatitis C virus infected patient on haemodialysis[J] . Clara TMM de Kanter,Jan G den Hollander,Corrien P.W.G.M. Verweij-van Wissen,David M. Burger.Journal of Clinical Virology . 2014
[8]
Meta‐analysis of observational studies: hepatitis C and survival after renal transplant[J] . F. Fabrizi,P. Martin,V. Dixit,P. Messa.J Viral Hepat . 2014 (5)
[10]
Prevalence of occult hepatitis C infection in chronic hemodialysis and kidney transplant patients[J] . Seema Baid-Agrawal,Ralf Schindler,Petra Reinke,Adrienne Staedtler,Sunda Rimpler,Barbara Malik,Ulrich Frei,Thomas Berg.Journal of Hepatology . 2014